| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Harrow, Inc. (HROW) has 8 insiders with recent SEC Form 4 filings, including 5 buys and 2 sells. HROW is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.99M | $126.64M | - | |
| CFO | 837.8K | $35.53M | - | |
| 10% | 70.0K | $2.97M | - | |
| Other | 30.0K | $1.27M | - | |
| Other | 15.0K | $636.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2016 | Boll Andrew R. | Chief Financial Officer | Buy | 39,000 | $1.79 | $69,810.00 | +260.0% | |
| Dec 19, 2016 | Baum Mark L66 | Chief Executive Officer | Buy | 156,000 | $1.79 | $279,240.00 | +91.9% | |
| Mar 11, 2016 | Opaleye Management Inc.60 | 10% Owner | Buy | 45,000 | $3.65 | $164,250.00 | +3.7% | |
| Jun 30, 2015 | Opaleye Management Inc.60 | 10% Owner | Buy | 35,000 | $7.90 | $276,500.00 | +3.0% | |
| May 19, 2015 | Opaleye Management Inc.60 | 10% Owner | Buy | 2,801 | $8.00 | $22,408.00 | +0.2% | |
| May 19, 2015 | Miloni Donald Paul | 10% Owner | Sell | 410,000 | $8.00 | $3,280,198.00 | -28.1% |